Grove City, OH – According to filings with the U.S. Securities and Exchange Commission, Forge Biologics is raising $40,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Timothy Miller played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Forge Biologics

Forge is a gene therapy development engine, enabling access to life changing discoveries by bringing them from concept to reality. We partner with innovators in the gene therapy community: scientists, physicians, biotech/pharma companies, and patient groups. We bring expertise in gene therapy manufacturing and therapeutics development to the table, helping champion teams that are navigating the long road from the lab bench to the bedside. Forge is currently building the Hearth, a 175,000 ft2 custom-designed cGMP facility, dedicated to AAV viral vector manufacturing. We offer end-to-end manufacturing services to accelerate gene therapy programs from preclinical stage through clinical, and on to commercial manufacturing.

To learn more about Forge Biologics, visit http://www.forgebiologics.com/

Contact:
Timothy Miller, Chief Executive Officer
216-287-5408
https://www.linkedin.com/in/timothy-j-miller-ph-d-5a387486/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved